AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Exploring ResMed’s Position in the Healthcare Sector
July 31, 2025 07:23 PM AEST| By Team Kalkine MediaHighlights,ResMed offers essential solutions for sleep and respiratory care.,Strong global presence supports steady demand for its services.,Healthcare sector remains resilient amid broader market shifts.,ResMed (ASX:RMD) has drawn considerable atten...
NeuroScientific (ASX:NSB) Gains Momentum with Progress in Peptide Therapies
July 31, 2025 06:29 PM AEST| By Team Kalkine MediaHighlights,NeuroScientific Biopharmaceuticals shows significant market momentum,The company is developing therapies for neurological and degenerative conditions,Share price growth outpaces reported earnings expansion,NeuroScientific Biopharmaceutical...
Austco Healthcare (ASX:AHC) Gains Momentum Amid Growth and Valuation Debate
July 31, 2025 06:06 PM AEST| By Team Kalkine MediaHighlights,Recent market performance reflects renewed attention,Earnings growth outpaces broader sector,Valuation cautious future expectations,Austco Healthcare (ASX:AHC) has seen renewed momentum in recent weeks, attracting interest following a nota...
Prescient Therapeutics (ASX:PTX) Accelerates Cancer Drug Trial with FDA Support
July 31, 2025 05:55 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics (ASX:PTX) advances its PTX-100 clinical trial after FDA Fast Track status,Company secures funding via Share Purchase Plan to support ongoing development,Expansion of trial sites in Australia, US, and Europe continues...
PainChek Expands Global Aged Care Reach as Clinical Trials Advance
July 31, 2025 04:23 PM AEST| By Team Kalkine MediaHighlights:,PainChek expands aged care reach across multiple global regions,New executive role created for US market expansion,Final submission made for FDA clearance of Adult App,The Australian health and biotech sector continues to evolve, with key...
Pro Medicus (ASX:PME): Radiology Tech Powerhouse in the ASX 100 Ranks
July 29, 2025 08:58 PM AEST| By Team Kalkine MediaHighlights,Strong global presence in medical imaging software,Visage platform enables real-time diagnostics,Strong financial position with zero net debt,Pro Medicus (PME), a constituent of the,ASX 100,, has carved a niche in the healthcare technology...
Vita Life Sciences (ASX:VLS) Sees Market Strength Backed by Solid Fundamentals
July 29, 2025 08:27 PM AEST| By Team Kalkine MediaHighlights,Vita Life Sciences shows efficient capital usage through strong ROE,Earnings growth aligns with broader industry performance,Market movement reflects financial consistency,Vita Life Sciences (ASX:VLS) has experienced a notable uplift in it...
Algorae Pharmaceuticals Enhances AI Drug Discovery Platform with Oncology Validation Progress
July 29, 2025 05:30 PM AEST| By Team Kalkine MediaHighlights,Strategic collaboration boosts cancer-focused AI predictions,Pre-clinical trials underway for novel drug combinations,Platform upgrade targets improved accuracy and performance,Algorae Pharmaceuticals (ASX:1AI) is advancing its AI-enabled...
Prescient Strengthens Cancer Drug Pipeline With Capital Raise
July 29, 2025 05:18 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics completes Share Purchase Plan to fund PTX-100 development,Launches follow-on placement as part of broader capital strategy,Focus remains on advancing precision oncology and immunotherapy platforms,Prescient Therapeut...
Prescient Therapeutics Secures Funding for Phase 2 Cancer Trials
July 29, 2025 03:43 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics completes Share Purchase Plan to progress PTX-100,Launches placement offer to meet extended funding interest,Clinical trial targets Cutaneous T cell lymphoma with global enrolment open,Prescient Therapeutics Ltd (ASX...
Why CSL (ASX:CSL) Continues to Draw Attention in the ASX 200 Healthcare Space
July 29, 2025 10:45 AM AEST| By Team Kalkine MediaHighlights,CSL,benefits,from stable healthcare demand,Positioned across key medical sectors,Healthcare sector draws ethical-focused interest,CSL (ASX:CSL), one of Australia's most recognised biotechnology companies, has maintained a strong presence w...
Radiopharm Theranostics Advances Novel Cancer Therapy with FDA Clearance
July 28, 2025 04:32 PM AEST| By Team Kalkine MediaHighlights,FDA greenlights Phase 1 trial for RV-01,Targeting B7H3 in solid tumours with novel therapy,Strategic isotope supply boosts development pipeline,Radiopharm Theranostics (ASX:RAD) has secured a significant milestone with investigational new...
Market Nerves Ahead of Key Inflation Data and Trump’s Tariff Clock: Implications for S&P 200
July 28, 2025 04:10 PM AEST| By Team Kalkine MediaHighlights:,Wall Street closed on a new high, but caution grips Australian markets,CPI release and Trump’s tariff plans are key near-term concerns,Investors assess implications across global and local stocks,With Wall Street pushing to a fresh high l...
Cochlear (ASX:COH): Strength in Healthcare and Steady Growth within ASX 200
July 28, 2025 03:06 PM AEST| By Team Kalkine MediaHighlights,Leading global brand in hearing implant technology,Resilient demand supports consistent performance,Aligned with rising focus on ethical healthcare,Cochlear (COH), based in Sydney and established in the early 1980s, is a globally recognise...
Is ResMed (ASX:RMD) Undervalued in 2025? | All Ordinaries Healthcare Stock with Global Tech Focus
July 27, 2025 07:28 PM AEST| By Team Kalkine MediaHighlights,Global healthcare firm with strong presence in sleep and respiratory care,Combines smart hardware with SaaS-driven efficiency,Financially robust with a conservative debt profile,ResMed (RMD) is a globally recognised medical technology comp...
ASX 200 Futures Watch: Clarity Pharmaceuticals (ASX:CU6) Surges Amid Anticipated Clinical Milestone
July 27, 2025 06:21 PM AEST| By Team Kalkine MediaHighlights:,Clarity Pharmaceuticals gains momentum on the ASX,Clinical trial developments boost investor sentiment,Market attention shifts to Co-PSMA study results,ASX 200 futures,edged higher on Thursday, buoyed by strong interest in biotech counter...
Telix Pharmaceuticals (ASX:TLX) Share Slide | R&D Strategy and Revenue Guidance in ASX 200 Biotech
July 27, 2025 06:06 PM AEST| By Team Kalkine MediaHighlights,Telix reaffirms revenue guidance despite recent share movement,Rising R&D marks shift toward innovation,Illuccix and RLS remain key revenue contributors,Telix Pharmaceuticals (TLX), a key biotechnology company listed on the,ASX 200,, exper...
Has Oneview Healthcare (ASX:ONE) Moved Ahead of Its Fundamentals?
July 26, 2025 04:57 PM AEST| By Team Kalkine MediaHighlights,Revenue growth has lagged behind other healthcare service peers,Recent share momentum may not reflect underlying business pace,Caution warranted if financials don’t align with current market sentiment,Oneview Healthcare (ASX:ONE) has exper...
CSL vs Pro Medicus: Exploring Healthcare Picks from ASX 200 in 2025
July 26, 2025 02:21 PM AEST| By Team Kalkine MediaHighlights,CSL and Pro Medicus operate in distinct segments of healthcare,CSL's strengths lie in mature pharma and biotech infrastructure,Pro Medicus is known for radiology-focused software solutions,When it comes to healthcare-focused,ASX 200,stocks...
Race Oncology’s RC220 Marks Clinical Advancement in ASX Biotech Landscape
July 25, 2025 05:23 PM AEST| By Team Kalkine MediaHighlights,First clinical trial dosing of RC220 completed,Broader application explored beyond leukemias,New leadership appointments reinforce trial execution,Race Oncology Ltd (ASX:RAC) has initiated clinical dosing of its novel compound RC220, a ref...
Advertise your brand on Kalkine Media